Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Wall Street Loses Faith in PayPal’s Near-Term Prospects

Robert Sasse by Robert Sasse
January 6, 2026
in Analysis, E-Commerce, Market Commentary, Nasdaq, Tech & Software
0
PayPal Stock
0
SHARES
40
VIEWS
Share on FacebookShare on Twitter

PayPal Holdings, Inc. is entering the new year facing a notable retreat in support from major financial institutions. A cluster of prominent investment banks have downgraded their outlooks for the digital payments company in a short span, citing concerns over weakening U.S. consumer spending and its direct impact on transaction volumes.

A Wave of Downgrades Hits the Stock

This pessimistic shift culminated on January 5, when Monness Crespi Hardt lowered its rating from “Buy” to “Neutral.” This move followed a series of similar actions by other heavyweight analysts in recent weeks:

  • JPMorgan issued a “Sell” recommendation on December 4, setting a price target of $70.
  • Bank of America downgraded the stock to “Neutral” on December 11, with a $68 target.
  • Morgan Stanley cut its rating to “Underweight” on December 18, projecting a share price of $51.

Citi analyst Bryan Keane maintained a “Hold” stance on January 5, but his price target of $60 offers minimal upside from the current trading level near $59.40, underscoring the widespread caution.

Institutional and Insider Selling Adds Pressure

The bearish sentiment extends beyond analyst notes. D.A. Davidson & Co. significantly reduced its stake, selling 66,407 shares in the third quarter—a cut of nearly 25%. This institutional selling was mirrored by activity within the company; corporate insiders disposed of more than 36,000 shares over the last three months.

Should investors sell immediately? Or is it worth buying PayPal?

Historically Cheap Valuation Fails to Attract Buyers

Despite the sell-off, PayPal’s fundamental metrics appear inexpensive. The stock trades at a price-to-earnings (P/E) ratio of just under 12, a level substantially below its historical average and far removed from the multiples above 20 common among other technology stocks. The business remains profitable, generating revenue of $32.91 billion and a net income of $4.92 per share.

However, the market is interpreting this low valuation as a warning sign rather than an opportunity. Shares are hovering close to their 52-week low of $55.85 and have declined approximately 30% year-over-year. Investors seemingly lack confidence in PayPal’s ability to sustain growth within the intensely competitive digital payments landscape.

All Eyes on the February Earnings Report

The company’s upcoming quarterly report, scheduled for February 3, 2026, is viewed as a critical test. It will reveal whether the current pessimistic analyst forecasts for 2026 are justified. Unless PayPal’s results and forward guidance deliver a positive surprise, the $60 price level is expected to act as a firm resistance point. The technical picture reinforces this downtrend, with the stock trading below both its 50-day moving average ($62.70) and its 200-day moving average ($67.81).

Ad

PayPal Stock: Buy or Sell?! New PayPal Analysis from March 25 delivers the answer:

The latest PayPal figures speak for themselves: Urgent action needed for PayPal investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

PayPal: Buy or sell? Read more here...

Tags: PayPal
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Zscaler Stock
Analysis

Zscaler’s Upward Revision: Security Demand in the AI Era Fuels Optimism

March 25, 2026
Coherent Stock
AI & Quantum Computing

Coherent Stock Accelerates Toward New Highs on Key Breakthroughs

March 25, 2026
Corning Stock
AI & Quantum Computing

Corning’s Strategic Alliance with Meta Fuels Investor Confidence

March 25, 2026
Next Post
Intel Stock

Intel Stock Gains Momentum on Key Product Launch and Analyst Upgrade

FS KKR Capital Stock

FS KKR Capital Shares Face Persistent Selling Pressure

ASML Stock

ASML Shares Surge to Record High Amid Semiconductor Boom

Recommended

UBS Stock

UBS Faces Critical Test as Quarterly Results Loom

2 months ago
Franklin FTSE India ETF Stock

India’s Growth Narrative Fails to Stem ETF Outflows

7 months ago
Technology Quantum computing Stock Exchange

Innovid Announces Fourth Quarter 2023 Financial Results and Provides Guidance for Full Year

2 years ago
Opendoor Stock

Opendoor Shares Face Sharp Correction Following Record Rally

7 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Dell’s Quantum Security Push Amidst AI-Driven Growth

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Trending

Zscaler Stock
Analysis

Zscaler’s Upward Revision: Security Demand in the AI Era Fuels Optimism

by Rodolfo Hanigan
March 25, 2026
0

At the recent RSA Conference, Zscaler’s leadership outlined a compelling vision, framing the company as a critical...

Coherent Stock

Coherent Stock Accelerates Toward New Highs on Key Breakthroughs

March 25, 2026
Corning Stock

Corning’s Strategic Alliance with Meta Fuels Investor Confidence

March 25, 2026
Dell Stock

Dell’s Quantum Security Push Amidst AI-Driven Growth

March 25, 2026
Gossamer Bio Stock

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Zscaler’s Upward Revision: Security Demand in the AI Era Fuels Optimism
  • Coherent Stock Accelerates Toward New Highs on Key Breakthroughs
  • Corning’s Strategic Alliance with Meta Fuels Investor Confidence

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com